CClinicalTrials.gg
RecruitingNCT07290387Updated May 14, 2026

Tele-Savvy for Latino Caregivers

An interventional study of Tele Savvy for Latino Caregivers in Alzheimer Disease, Dementia and Caregiver Stress, sponsored by University of Rochester. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by University of Rochester · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Apr 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Latino caregivers of individuals with Alzheimer's disease and related dementias experience high levels of stress burden and depressive symptoms and are underrepresented in caregiver intervention research. Tele Savvy is an evidence based caregiver education program that focuses on developing caregiver mastery skills. This study aims to culturally adapt the Tele Savvy intervention for Latino caregivers and evaluate its preliminary efficacy in a Stage 1b single arm clinical trial. The intervention is delivered remotely and includes weekly group sessions and asynchronous instructional videos. Primary outcomes focus on caregiver mastery with secondary outcomes including stress burden depressive symptoms and self efficacy.

02

Conditions studied

  • Alzheimer Disease
  • Dementia
  • Caregiver Stress
03

In context

Alzheimer Disease

3,678 studies on the registry are indexed under Alzheimer Disease; 872 are open to participants now.

This study's planned enrollment of 64 is close to the median of 70 across 2,808 interventional studies indexed under Alzheimer Disease.

Browse Alzheimer Disease studies →

Lead sponsor

University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Identify as Hispanic or Latino
  • Age 18 years or older
  • Spanish speaking and able to read and write in Spanish
  • Provide at least four hours per week of care to a community dwelling loved one with Alzheimer's disease or related dementias
  • Have access to an electronic device and internet
  • Willing to participate in study interviews and intervention sessions

Exclusion criteria

Exclusion Criteria:

  • Physical or sensory conditions preventing use of a computer tablet or smartphone
  • Planning to move the care recipient to an institutional setting within six months
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Intervention

    Behavioral: Tele Savvy for Latino Caregivers

Interventions

  • BehavioralTele Savvy for Latino Caregivers

    Tele Savvy for Latino Caregivers is a culturally adapted seven week caregiver education and support program delivered remotely. Participants attend weekly ninety minute group sessions via videoconference and receive two to three asynchronous instructional videos per week. The intervention focuses on developing caregiver mastery skills including caregiving competence confidence and stress management.

06

What researchers measure

Primary outcomes

  1. Mean Change in Caregiver Mastery Score

    Caregiver mastery is measured using two Pearlin Caregivers' Stress subscales: Caregiving Competence and Confidence and Management of Situation. Each subscale consists of four Likert type items. Item responses are scored according to published scoring instructions and summed to produce a total caregiver mastery score for each participant at each assessment time point. The outcome is defined as the mean change in the total caregiver mastery score from baseline to three months post intervention across participants.

    Time frame: Baseline to three months post intervention completion

Secondary outcomes

  1. Mean Change in Perceived Stress Scale Score

    Perceived stress is measured using the 10 item Perceived Stress Scale. Each item is scored on a Likert type scale according to standard scoring procedures, with designated items reverse scored. Item scores are summed to generate a total Perceived Stress Scale score for each participant at each assessment time point. The outcome is defined as the mean change in the total Perceived Stress Scale score from baseline to three months post intervention.

    Time frame: Baseline to Three Months Post Intervention

  2. Mean Change in Total Zarit Caregiver Burden Scale Score

    Caregiver burden is measured using the Zarit Caregiver Burden Scale. Individual item responses are scored and summed to produce a total Zarit Burden score for each participant at each assessment time point. The outcome is defined as the mean change in the total Zarit Caregiver Burden Scale score from baseline to three months post intervention.

    Time frame: Baseline to Three Months Post Intervention

  3. Mean Change in Total CES D R Depression Score

    Depressive symptoms are measured using the Center for Epidemiologic Studies Depression Scale Revised. Item responses are scored according to standard scoring procedures and summed to generate a total CES D R score for each participant at each assessment time point. The outcome is defined as the mean change in the total CES D R score from baseline to three months post intervention.

    Time frame: Baseline to Three Months Post Intervention

  4. Mean Change in Total Family Caregiver Self Efficacy for Managing Dementia Score

    Caregiver self efficacy is measured using the Family Caregiver Self Efficacy for Managing Dementia questionnaire. Item responses are scored and summed to generate a total self efficacy score for each participant at each assessment time point. The outcome is defined as the mean change in the total caregiver self efficacy score from baseline to three months post intervention.

    Time frame: Baseline to Three Months Post Intervention

  5. Mean Total Satisfaction Questionnaire Score Immediately Post Intervention

    Participant satisfaction is measured using a satisfaction questionnaire administered immediately after intervention completion. Item responses are scored and summed to produce a total satisfaction score for each participant. The outcome is defined as the mean total satisfaction questionnaire score across participants.

    Time frame: Immediately following completion of the seven week intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07290387
Lead sponsor
University of Rochester
Collaborators
National Institute on Aging (NIA)
Responsible party
Maria Quinones (Assistant Professor of Clinical Nursing, University of Rochester) — Principal investigator
First posted
Dec 18, 2025
Start date
Apr 17, 2026
Primary completion
Apr 30, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
May 14, 2026

Study contacts

Maria Quiñones, PhD
Contact
Maria_Quinones@URMC.Rochester.edu
(585) 276-3903

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion